Sunitinib Combined with Th1 Cytokines Potentiates Apoptosis in Human Breast Cancer Cells and Suppresses Tumor Growth in a Murine Model of HER-2(pos) Breast Cancer

Although immune-based therapies have made remarkable inroads in cancer treatment, they usually must be combined with standard treatment modalities, including cytotoxic drugs, to achieve maximal clinical benefits. As immunotherapies are further advanced and refined, considerable efforts will be requi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghimirey, Nirmala, Steele, Chase, Czerniecki, Brian J., Koski, Gary K., Showalter, Loral E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062178/
https://www.ncbi.nlm.nih.gov/pubmed/33936816
http://dx.doi.org/10.1155/2021/8818393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062178/
https://www.ncbi.nlm.nih.gov/pubmed/33936816
http://dx.doi.org/10.1155/2021/8818393

Ejemplares similares